Skip to main content
Erschienen in: Pediatric Nephrology 2/2006

01.02.2006 | Review

Ontogeny of drug elimination by the human kidney

verfasst von: Nancy Chen, Katarina Aleksa, Cindy Woodland, Michael Rieder, Gideon Koren

Erschienen in: Pediatric Nephrology | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Renal clearance is an important route of drug elimination. While during the neonatal period there is minimal glomerular filtration and active tubular secretion of drugs, there is a well-described rapid development in these processes in the post-neonatal period. A less appreciated fact is that during toddlerhood, there is an “overshoot” of the glomerular filtration rate (GFR) well above the levels encountered in older children and adults, and there is an early achievement of adult levels in active drug secretion, which stays at a plateau throughout childhood and adulthood with an “overshoot” in toddlers due to specific transport mechanisms. This phenomenon leads to dose requirements for renally excreted drugs in this age group being, on a per-kilogram basis, much larger than in adults. This review discusses the mechanisms related to renal ontogeny in drug handling.
Literatur
1.
Zurück zum Zitat Jungbluth GL, Welshman IR, Hopkins NK (2003) Linezolid pharmacokinetics in pediatric patients: an overview. Pediatr Infect Dis J 22:S153–157PubMed Jungbluth GL, Welshman IR, Hopkins NK (2003) Linezolid pharmacokinetics in pediatric patients: an overview. Pediatr Infect Dis J 22:S153–157PubMed
2.
Zurück zum Zitat Kearns GL, Jungbluth GL, Abdel-Rahman SM, Hopkins NK, Welshman IR, Grzebyk RP, Bruss JB, Van Den Anker JN; Pediatric Pharmacology Research Unit Network (2003) Impact of ontogeny on linezolid disposition in neonates and infants. Clin Pharmacol Ther 74:413–422CrossRefPubMed Kearns GL, Jungbluth GL, Abdel-Rahman SM, Hopkins NK, Welshman IR, Grzebyk RP, Bruss JB, Van Den Anker JN; Pediatric Pharmacology Research Unit Network (2003) Impact of ontogeny on linezolid disposition in neonates and infants. Clin Pharmacol Ther 74:413–422CrossRefPubMed
3.
Zurück zum Zitat Yaffe, SJ, Aranda JV, Kauffman RE (2005) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn, chapter 3. Lippincott Williams & Wilkins, Philadelphia, pp 20–31 Yaffe, SJ, Aranda JV, Kauffman RE (2005) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn, chapter 3. Lippincott Williams & Wilkins, Philadelphia, pp 20–31
4.
Zurück zum Zitat Solhaug MJ, Bolger PM, Jose PA (2004) The developing kidney and environmental toxins. Pediatrics 113:1084–1091PubMed Solhaug MJ, Bolger PM, Jose PA (2004) The developing kidney and environmental toxins. Pediatrics 113:1084–1091PubMed
5.
Zurück zum Zitat Akaoka K, White RH, Raafat F (1994) Human glomerular growth during childhood: A morphometric study. J Pathol 173:261–268CrossRefPubMed Akaoka K, White RH, Raafat F (1994) Human glomerular growth during childhood: A morphometric study. J Pathol 173:261–268CrossRefPubMed
7.
Zurück zum Zitat Akaoka K, White RH, Raafat F (1995) Glomerular morphometry in childhood reflux nephropathy, emphasizing the capillary changes. Kidney Int 47:1108–1114PubMed Akaoka K, White RH, Raafat F (1995) Glomerular morphometry in childhood reflux nephropathy, emphasizing the capillary changes. Kidney Int 47:1108–1114PubMed
8.
Zurück zum Zitat Li M, Nicholls KM, Becker GJ (2002) Glomerular size and global glomerulosclerosis in normal Caucasian donor kidneys: effects of aging and gender. J Nephrol 15:614–619PubMed Li M, Nicholls KM, Becker GJ (2002) Glomerular size and global glomerulosclerosis in normal Caucasian donor kidneys: effects of aging and gender. J Nephrol 15:614–619PubMed
9.
Zurück zum Zitat Yaffe, SJ, Aranda JV, Anker van den JN (2005) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn, chapter 15. Lippincott Williams Wilkins, Philadelphia, pp 172–186 Yaffe, SJ, Aranda JV, Anker van den JN (2005) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn, chapter 15. Lippincott Williams Wilkins, Philadelphia, pp 172–186
10.
Zurück zum Zitat Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology—drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157–1167CrossRefPubMed Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology—drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157–1167CrossRefPubMed
11.
Zurück zum Zitat Fleming JS, Persaud L, Zivanovic MA (2005) A general equation for estimating glomerular filtration rate from a single plasma sample. Nucl Med Commun 26:743–748CrossRefPubMed Fleming JS, Persaud L, Zivanovic MA (2005) A general equation for estimating glomerular filtration rate from a single plasma sample. Nucl Med Commun 26:743–748CrossRefPubMed
12.
Zurück zum Zitat Leger F, Bouissou F, Coulais Y, Tafani M, Chatelut E (2002) Estimation of glomerular filtration rate in children. Pediatr Nephrol 17:903–907CrossRefPubMed Leger F, Bouissou F, Coulais Y, Tafani M, Chatelut E (2002) Estimation of glomerular filtration rate in children. Pediatr Nephrol 17:903–907CrossRefPubMed
13.
Zurück zum Zitat Hellerstein S, Berenbom M, Erwin P, Wilson N, DiMaggio S (2004) Measurement of renal functional reserve in children. Pediatr Nephrol 19:1132–1136PubMed Hellerstein S, Berenbom M, Erwin P, Wilson N, DiMaggio S (2004) Measurement of renal functional reserve in children. Pediatr Nephrol 19:1132–1136PubMed
14.
Zurück zum Zitat Bardi E, Bobok I, Olah AV, Olah E, Kappelmayer J, Kiss C (2004) Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145–1147PubMed Bardi E, Bobok I, Olah AV, Olah E, Kappelmayer J, Kiss C (2004) Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145–1147PubMed
15.
Zurück zum Zitat Hayton WL (2000) Maturation and growth of renal function: dosing renally cleared drugs in children. AAPS PharmSci 2:1–7CrossRef Hayton WL (2000) Maturation and growth of renal function: dosing renally cleared drugs in children. AAPS PharmSci 2:1–7CrossRef
16.
Zurück zum Zitat Rubin M, Bruck E, Rappoport M (1949) Maturation of renal function in childhood: clearance studies. J Clin Invest 28:1144–1162 Rubin M, Bruck E, Rappoport M (1949) Maturation of renal function in childhood: clearance studies. J Clin Invest 28:1144–1162
17.
Zurück zum Zitat Smith WW, Finkelstein N, Smith HW (1940) Renal excretion of hexitols and their derivatives and of endogenous creatinine-like chromogen in dog and man. J Biol Chem 135:231–250 Smith WW, Finkelstein N, Smith HW (1940) Renal excretion of hexitols and their derivatives and of endogenous creatinine-like chromogen in dog and man. J Biol Chem 135:231–250
18.
Zurück zum Zitat Sweet DH, Bush KT, Nigam SK (2001) The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Renal Physiol 281:F197–F205 Sweet DH, Bush KT, Nigam SK (2001) The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Renal Physiol 281:F197–F205
19.
Zurück zum Zitat Hook JB, Hewitt WR (1977) Development of mechanisms for drug excretion. Am J Med 62:497–506CrossRefPubMed Hook JB, Hewitt WR (1977) Development of mechanisms for drug excretion. Am J Med 62:497–506CrossRefPubMed
20.
Zurück zum Zitat Ruth EB (1935) Metamorphosis of the pubic symphysis. I. The white rat ( Mus norvegicus albinus). Anat Rec 64:1–7CrossRef Ruth EB (1935) Metamorphosis of the pubic symphysis. I. The white rat ( Mus norvegicus albinus). Anat Rec 64:1–7CrossRef
21.
Zurück zum Zitat Dutt A, Priebe TS, Teeter LD, Kuo MT, Nelson JA (1992) Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther 261:1222–1230PubMed Dutt A, Priebe TS, Teeter LD, Kuo MT, Nelson JA (1992) Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther 261:1222–1230PubMed
22.
Zurück zum Zitat Pinto N, Halachmi N, Woodland C, Koren G (2004) Ontogeny of renal P-glycoprotein expression in mice: implications for pediatric dosing. Clin Pharmacol Ther 75:25 http://www.ascpt.org/press/2004/2004Abstracts.pdf Pinto N, Halachmi N, Woodland C, Koren G (2004) Ontogeny of renal P-glycoprotein expression in mice: implications for pediatric dosing. Clin Pharmacol Ther 75:25 http://​www.​ascpt.​org/​press/​2004/​2004Abstracts.​pdf
23.
Zurück zum Zitat Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and Cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387CrossRefPubMed Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and Cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387CrossRefPubMed
24.
Zurück zum Zitat Marchi AG, Messi G, Loschi L (1991) Evaluation of changing patterns in children poisonings and prevention. Vet Hum Toxicol 33:244–246PubMed Marchi AG, Messi G, Loschi L (1991) Evaluation of changing patterns in children poisonings and prevention. Vet Hum Toxicol 33:244–246PubMed
25.
Zurück zum Zitat Litovitz TL, Flagler SL, Manoguerra AS, Veltri JC, Wright L (1989) Recurrent poisonings among paediatric poisoning victims. Med Toxicol Adverse Drug Exp 4:381–386PubMed Litovitz TL, Flagler SL, Manoguerra AS, Veltri JC, Wright L (1989) Recurrent poisonings among paediatric poisoning victims. Med Toxicol Adverse Drug Exp 4:381–386PubMed
26.
Zurück zum Zitat Anders MW (1980) Metabolism of drugs by the kidney. Kidney Int 18:636–647PubMed Anders MW (1980) Metabolism of drugs by the kidney. Kidney Int 18:636–647PubMed
27.
Zurück zum Zitat Daugaard G, Abildgaard U, Larsen S, Holstein-Rathlou NH, Amtorp O, Olesen HP, Leyssac PP (1987) Functional and histopathological changes in dog kidneys after administration of cisplatin. Renal Physiol 10:54–64PubMed Daugaard G, Abildgaard U, Larsen S, Holstein-Rathlou NH, Amtorp O, Olesen HP, Leyssac PP (1987) Functional and histopathological changes in dog kidneys after administration of cisplatin. Renal Physiol 10:54–64PubMed
28.
Zurück zum Zitat Rossi RM, Kist C, Wurster U, Kulpmann WR, Ehrich JH (1994) Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatr Nephrol 8:151–156CrossRefPubMed Rossi RM, Kist C, Wurster U, Kulpmann WR, Ehrich JH (1994) Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatr Nephrol 8:151–156CrossRefPubMed
29.
Zurück zum Zitat Shore R, Greenberg M, Geary D, Koren G (1992) Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol 6:162–165CrossRefPubMed Shore R, Greenberg M, Geary D, Koren G (1992) Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol 6:162–165CrossRefPubMed
30.
Zurück zum Zitat Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW (1992) The influence of age on nephrotoxicity following chemotherapy in children. Br J Cancer [Suppl] 18:S30–35 Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW (1992) The influence of age on nephrotoxicity following chemotherapy in children. Br J Cancer [Suppl] 18:S30–35
31.
Zurück zum Zitat Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW (1990) Nephrotoxicity after ifosfamide. Arch Dis Child 65:732–738PubMed Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW (1990) Nephrotoxicity after ifosfamide. Arch Dis Child 65:732–738PubMed
32.
Zurück zum Zitat Aleksa K, Halachmi N, Ito S, Koren G (2004) Renal ontogeny of ifosfamide nephrotoxicity. J Lab Clin Med 144:285–293CrossRefPubMed Aleksa K, Halachmi N, Ito S, Koren G (2004) Renal ontogeny of ifosfamide nephrotoxicity. J Lab Clin Med 144:285–293CrossRefPubMed
33.
Zurück zum Zitat Hoyer AF (1989) Optimal use of cyclosporine A in children. Pediatr Nephrol 3:C85–90 Hoyer AF (1989) Optimal use of cyclosporine A in children. Pediatr Nephrol 3:C85–90
34.
Zurück zum Zitat Termeer A, Hoitsma AJ, Koene RA (1986) Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients. Transplantation 42:220–221PubMed Termeer A, Hoitsma AJ, Koene RA (1986) Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients. Transplantation 42:220–221PubMed
35.
Zurück zum Zitat Blowey DL, Ben-David S, Koren G (1995) Interactions of drugs with the developing kidney. Pediatr Clin North Am 42:1415–1431PubMed Blowey DL, Ben-David S, Koren G (1995) Interactions of drugs with the developing kidney. Pediatr Clin North Am 42:1415–1431PubMed
36.
Zurück zum Zitat Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572PubMed Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572PubMed
37.
Zurück zum Zitat Goldstein RS, Hook JB (1992) Biochemical mechanisms of nephrotoxicity. In: Edelmann CM Jr (ed) Pediatric kidney disease, 2nd edn. Little, Brown and Company, Boston, p 417 Goldstein RS, Hook JB (1992) Biochemical mechanisms of nephrotoxicity. In: Edelmann CM Jr (ed) Pediatric kidney disease, 2nd edn. Little, Brown and Company, Boston, p 417
38.
Zurück zum Zitat Nielsen TW, Maaske CA, Booth NH (1969) Some comparative aspects of porcine renal function. In: Bustad LK, McClellan RO (eds) Swine in biomedical research. Pacific Northwest Laboratory, Seattle, pp 529–536 Nielsen TW, Maaske CA, Booth NH (1969) Some comparative aspects of porcine renal function. In: Bustad LK, McClellan RO (eds) Swine in biomedical research. Pacific Northwest Laboratory, Seattle, pp 529–536
39.
Zurück zum Zitat Friis C (1983) Renal excretion of drugs during postnatal development in piglets. Vet Res Commun 7:349–52CrossRefPubMed Friis C (1983) Renal excretion of drugs during postnatal development in piglets. Vet Res Commun 7:349–52CrossRefPubMed
40.
Zurück zum Zitat Friis C (1980) Postnatal development of the pig kidney: ultrastucure of the glomerulus and the proximal tubule. J Anat 130:513–526PubMed Friis C (1980) Postnatal development of the pig kidney: ultrastucure of the glomerulus and the proximal tubule. J Anat 130:513–526PubMed
41.
Zurück zum Zitat Soucek P, Zuber R, Anzenbacherova E, Anzenbacher P, Guengerich FP (2001) Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol 1:11–15CrossRefPubMed Soucek P, Zuber R, Anzenbacherova E, Anzenbacher P, Guengerich FP (2001) Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol 1:11–15CrossRefPubMed
42.
Zurück zum Zitat Potter D, Jarrah A, Sakai T, Harrah J, Holliday MA (1969) Character of function and size in kidney during normal growth of rats. Pediatr Res 3:51–59PubMed Potter D, Jarrah A, Sakai T, Harrah J, Holliday MA (1969) Character of function and size in kidney during normal growth of rats. Pediatr Res 3:51–59PubMed
43.
Zurück zum Zitat Solomon S (1977) Developmental changes in nephron number, proximal tubular length and superficial nephron glomerular filtration rate of rats. J Physiol 272:573–589PubMed Solomon S (1977) Developmental changes in nephron number, proximal tubular length and superficial nephron glomerular filtration rate of rats. J Physiol 272:573–589PubMed
44.
Zurück zum Zitat Bonvalet JP, Champion M, Wanstok F, Berjal G (1972) Compensatory renal hypertrophy in young rats: Increase in the number of nephrons. Kidney Int 1:391–396PubMed Bonvalet JP, Champion M, Wanstok F, Berjal G (1972) Compensatory renal hypertrophy in young rats: Increase in the number of nephrons. Kidney Int 1:391–396PubMed
45.
Zurück zum Zitat Horster M, Lewy JE (1970) Filtration fraction and extraction of PAH during neonatal period in the rat. Am J Physiol 21:1061–1065 Horster M, Lewy JE (1970) Filtration fraction and extraction of PAH during neonatal period in the rat. Am J Physiol 21:1061–1065
46.
Zurück zum Zitat Chamaa NS, Mosig D, Drukker A, Guignard JP (2000) The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 48:600–605PubMed Chamaa NS, Mosig D, Drukker A, Guignard JP (2000) The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 48:600–605PubMed
47.
Zurück zum Zitat Drukker A, Mosig D, Guignard JP (2001) The renal hemodynamic effects of aspirin in newborn and young adult rabbits. Pediatr Nephrol 16:713–718CrossRefPubMed Drukker A, Mosig D, Guignard JP (2001) The renal hemodynamic effects of aspirin in newborn and young adult rabbits. Pediatr Nephrol 16:713–718CrossRefPubMed
48.
Zurück zum Zitat Ballevre L, Thonney M, Guignard JP (1996) Nitric oxide modulates glomerular filtration and renal blood flow of the newborn rabbit. Biol Neonate 69:389–398PubMed Ballevre L, Thonney M, Guignard JP (1996) Nitric oxide modulates glomerular filtration and renal blood flow of the newborn rabbit. Biol Neonate 69:389–398PubMed
49.
Zurück zum Zitat Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD (2002) Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301:145–151CrossRefPubMed Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD (2002) Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301:145–151CrossRefPubMed
50.
Zurück zum Zitat Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and Cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387CrossRefPubMed Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and Cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387CrossRefPubMed
51.
Zurück zum Zitat Mahmood B, Daood MJ, Hart C, Hansen TW, Watchko JF (2001) Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investing Med 49:250–257 Mahmood B, Daood MJ, Hart C, Hansen TW, Watchko JF (2001) Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investing Med 49:250–257
52.
Zurück zum Zitat Rane A, Wilson JT (1976) Clinical pharmacokinetics in infants and children. Clin Pharmacokinet 1:2–24PubMed Rane A, Wilson JT (1976) Clinical pharmacokinetics in infants and children. Clin Pharmacokinet 1:2–24PubMed
53.
Zurück zum Zitat Mamzoridi K, Kasteridou N, Peonides A, Niopas I (1996) Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose. Pharmacol Toxicol 78:417–420PubMed Mamzoridi K, Kasteridou N, Peonides A, Niopas I (1996) Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose. Pharmacol Toxicol 78:417–420PubMed
54.
Zurück zum Zitat Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatr Nephrol 19:271–275CrossRefPubMed Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatr Nephrol 19:271–275CrossRefPubMed
55.
Zurück zum Zitat Noormohamed FH, McNabb WR, Lant AF (1990) Pharmacokinetic and pharmacodynamic actions of enalapril in humans: effect of probenecid pretreatment. J Pharmacol Exp Ther 253:362–368PubMed Noormohamed FH, McNabb WR, Lant AF (1990) Pharmacokinetic and pharmacodynamic actions of enalapril in humans: effect of probenecid pretreatment. J Pharmacol Exp Ther 253:362–368PubMed
56.
Zurück zum Zitat Morrison RA, Singhvi SM, Creasey WA, Willard DA (1988) Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects. Eur J Clin Pharmacol 33:625–628CrossRefPubMed Morrison RA, Singhvi SM, Creasey WA, Willard DA (1988) Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects. Eur J Clin Pharmacol 33:625–628CrossRefPubMed
57.
Zurück zum Zitat Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI, Lippe BH (1992) Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 2:S274–283PubMed Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI, Lippe BH (1992) Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 2:S274–283PubMed
58.
Zurück zum Zitat Naber KG, Westenfelder SR, Madsen PO (1973) Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother 3:469–473PubMed Naber KG, Westenfelder SR, Madsen PO (1973) Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother 3:469–473PubMed
59.
Zurück zum Zitat Bauer LA, Blouin RA (1982) Gentamicin pharmacokinetics: effect of aging in patients with normal renal function. J Am Geriatr Soc 30:309–311PubMed Bauer LA, Blouin RA (1982) Gentamicin pharmacokinetics: effect of aging in patients with normal renal function. J Am Geriatr Soc 30:309–311PubMed
60.
Zurück zum Zitat Albert KS, Gernaat CM (1984) Pharmacokinetics of ibuprofen. Am J Med. 77:40–46 Albert KS, Gernaat CM (1984) Pharmacokinetics of ibuprofen. Am J Med. 77:40–46
61.
Zurück zum Zitat Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18:364–373PubMed Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18:364–373PubMed
62.
Zurück zum Zitat Gyselynck AM, Forrey A, Cutler R (1971) Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. J Infect Dis 124:S70–76 Gyselynck AM, Forrey A, Cutler R (1971) Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. J Infect Dis 124:S70–76
63.
Zurück zum Zitat Benson JM, Nahata MC (1989) Pharmacokinetics of amphotericin C in children. Antimicrob Agents Chemother 33:1989–1993PubMed Benson JM, Nahata MC (1989) Pharmacokinetics of amphotericin C in children. Antimicrob Agents Chemother 33:1989–1993PubMed
64.
Zurück zum Zitat Creasey WA, Funke PT, McKindstry DN, Sugerman AA (1986) Pharmacokinetics of captopril in elderly healthy male volunteers. J Clin Pharmacol 26:264–268PubMed Creasey WA, Funke PT, McKindstry DN, Sugerman AA (1986) Pharmacokinetics of captopril in elderly healthy male volunteers. J Clin Pharmacol 26:264–268PubMed
65.
Zurück zum Zitat Duchin KL, Singhvi SM, Willard DA, Migdalof BH, McKinstry DN (1982) Captopril kinetics. Clin Pharmacol Ther 31:452–458PubMed Duchin KL, Singhvi SM, Willard DA, Migdalof BH, McKinstry DN (1982) Captopril kinetics. Clin Pharmacol Ther 31:452–458PubMed
66.
Zurück zum Zitat Dreyfuss J, Brannick LJ, Vukovich RA, Shaw JM, Willard DA (1977) Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol 17:300–307PubMed Dreyfuss J, Brannick LJ, Vukovich RA, Shaw JM, Willard DA (1977) Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol 17:300–307PubMed
67.
Zurück zum Zitat Mehta AV, Chidambaram B, Rice PJ (1992) Pharmacokinetics of nadolol in children with supraventricular tachycardia. J Clin Pharmacol 32:1023–1027PubMed Mehta AV, Chidambaram B, Rice PJ (1992) Pharmacokinetics of nadolol in children with supraventricular tachycardia. J Clin Pharmacol 32:1023–1027PubMed
68.
Zurück zum Zitat Gomeni R, Bianchetti G, Sega R, Morselli PL (1977) Pharmacokinetics of propranolol in normal healthy volunteers. J Pharmacokinet Biopharm 5:183–192CrossRefPubMed Gomeni R, Bianchetti G, Sega R, Morselli PL (1977) Pharmacokinetics of propranolol in normal healthy volunteers. J Pharmacokinet Biopharm 5:183–192CrossRefPubMed
69.
Zurück zum Zitat Gorodischer R, Jusko WJ, Yaffe SJ (1977) Renal clearance of digoxin in young infants. Res Commun Chem Pathol Pharmacol 16:363–374PubMed Gorodischer R, Jusko WJ, Yaffe SJ (1977) Renal clearance of digoxin in young infants. Res Commun Chem Pathol Pharmacol 16:363–374PubMed
70.
Zurück zum Zitat Griffith RS (1983) The pharmacology of cephalexin. Postgrad Med J 59:16–27PubMed Griffith RS (1983) The pharmacology of cephalexin. Postgrad Med J 59:16–27PubMed
71.
Zurück zum Zitat Han EE, Beringer PM, Louis SG, Gill MA, Shapiro BJ (2004) Pharmacokinetics of ibuprofen in children with cystic fibrosis. Clin Pharmacokinet 43:145–156PubMed Han EE, Beringer PM, Louis SG, Gill MA, Shapiro BJ (2004) Pharmacokinetics of ibuprofen in children with cystic fibrosis. Clin Pharmacokinet 43:145–156PubMed
72.
Zurück zum Zitat Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A (1988) Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. Clin Pharmacokinet 15:57–65PubMed Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A (1988) Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. Clin Pharmacokinet 15:57–65PubMed
73.
Zurück zum Zitat Hoecker JL, Pickering LK, Swaney J, Kramer WG, van Eys J, Feldman S, Kohl S (1978) Clinical pharmacology of tobramycin in children. J Infect Dis 137:592–596PubMed Hoecker JL, Pickering LK, Swaney J, Kramer WG, van Eys J, Feldman S, Kohl S (1978) Clinical pharmacology of tobramycin in children. J Infect Dis 137:592–596PubMed
74.
Zurück zum Zitat Isalo E (1977) Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 2:1–16PubMed Isalo E (1977) Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 2:1–16PubMed
75.
Zurück zum Zitat Levy M, Koren G, Klein J, McLorie G, Balfe JW (1991) Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. Dev Pharmacol Ther 16:185–193PubMed Levy M, Koren G, Klein J, McLorie G, Balfe JW (1991) Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. Dev Pharmacol Ther 16:185–193PubMed
76.
Zurück zum Zitat Ochs HR, Greenblatt DJ, Bodem G, Harmatz JS (1978) Dose-independent pharmacokinetics of digoxin in humans. Am Heart J 96:507–511CrossRefPubMed Ochs HR, Greenblatt DJ, Bodem G, Harmatz JS (1978) Dose-independent pharmacokinetics of digoxin in humans. Am Heart J 96:507–511CrossRefPubMed
77.
Zurück zum Zitat Olkkola KT, Maunuksela EL, Korpela R (1989) Pharmacokinetics of postoperative intravenous indomethacin in children. Pharmacol Toxicol 65:157–160PubMed Olkkola KT, Maunuksela EL, Korpela R (1989) Pharmacokinetics of postoperative intravenous indomethacin in children. Pharmacol Toxicol 65:157–160PubMed
78.
Zurück zum Zitat Richer C, Giroux B, Plouin PF, Maarek b, Giudicelli JF (1984) Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. Br J Clin Pharmacol 17:243–250PubMed Richer C, Giroux B, Plouin PF, Maarek b, Giudicelli JF (1984) Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. Br J Clin Pharmacol 17:243–250PubMed
79.
Zurück zum Zitat Roberts CJ (1984) Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet 9:211–221PubMed Roberts CJ (1984) Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet 9:211–221PubMed
80.
Zurück zum Zitat Stoeckel K, Hayton WL, Edwards DJ (1995) Clinical pharmacokinetics of oral cephalosporines. Antibiot Chemother 47:34–71PubMed Stoeckel K, Hayton WL, Edwards DJ (1995) Clinical pharmacokinetics of oral cephalosporines. Antibiot Chemother 47:34–71PubMed
81.
Zurück zum Zitat Mitchell RI, Barratt MT (1975) Pediatric nephrology, chapter 1. Williams Wilkins, Baltimore Mitchell RI, Barratt MT (1975) Pediatric nephrology, chapter 1. Williams Wilkins, Baltimore
Metadaten
Titel
Ontogeny of drug elimination by the human kidney
verfasst von
Nancy Chen
Katarina Aleksa
Cindy Woodland
Michael Rieder
Gideon Koren
Publikationsdatum
01.02.2006
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 2/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-2105-4

Weitere Artikel der Ausgabe 2/2006

Pediatric Nephrology 2/2006 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.